Chronic heaptitis C virus infection is associated with more severe asthma

Allergology International

Volumn 60, Issue 3, 2011, Pages 299-304

  Nakashima, Taku ^a   Yokoyama', Akihito ^a,b   Ohnishi, Hiroshi ^a,b   Yamasaki, Masahiro ^c,d   Shiode, Masahiro ^e,f   Haruta, Yoshinori ^a   Hattori, Noboru ^a   Hozawa, Soichiro ^g   Yamakido, Hideto ^h   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KOCHI UNIVERSITY   (Japan)

^c HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^d ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^e Uwajima City Hospital   (Japan)

^f Ehime Prefectural Niihama Hospital   (Japan)

^g Hiroshima Res and Devmt Center   (Japan)

^h Hiroshima Municipal Funairi Hospital   (Japan)

Author keywords

Global initiative for asthma; Hepatitis B virus; Hepatitis C virus; Severe asthma; Severity of asthma

Indexed keywords

CORTICOSTEROID; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA; HEPATITIS ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; ATOPY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; ASTHMA; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; RNA, VIRAL; YOUNG ADULT;

EID: 80052650956     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0240     Document Type: Article

References (19)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated December 2008. Available at: http://www.ginasthma.org. Accessed October 12, 2009.
2. Camargo CA Jr, Barr RG, Chen R, Speizer FE. Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest 2008;134:546-51.
3. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. NEnglJMed 2000;343:332-6.
4. Wenzel SE, Busse WWW; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:14-21.
5. Holgate ST, Polosa R The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006; 368:780-93.
6. Chanez P, Wenzel SE, Anderson GP et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 2007; 119:1337-48.
7. Haughney J, Price D, Kaplan A et al. Achieving asthma control in practice: understanding the reasons for poor control. RespirMed 2008;102:1681-93.
8. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905-17.
9. Iwamoto H, Yokoyama A, Shiota N et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. EurRespirJ 2008;31:1379-80.
10. Yamauchi K, Inoue H. Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling. Allergol Int 2007;56:321-9.
11. Miller GE, Gaudin A, Zysk E, Chen E. Parental support and cytokine activity in childhood asthma: the role of glu-cocorticoid sensitivity. J Allergy Clin Immunol 2009; 123:824-30.
12. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009;180:817-22.
13. Moorman J, Saad M, Kosseifi S, Krishnaswamy G. Hepatitis C virus and the lung: implications for therapy. Chest 2005;128:2882-92.
14. Kanazawa H, Yoshikawa J. Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. AmJMed 2004;116:749-52.
15. Kanazawa H, Mamoto T, Hirata K, Yoshikawa J. Inter-feron therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection: a preliminary study. Chest 2003;123:600-3.
16. Iwamoto H, Yokoyama A, Kitahara Y et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009;179:35-40.
17. Tanaka J, Kumagai J, Katayama K et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology 2004;47:32-40.
18. Kanazawa H, Yoshikawa J. Alterations in T-lymphocyte subsets in the airways of asthmatic patients with active hepatitis C virus infection. Respiration 2006;73:318-23.
19. Moorman JP, Fitzgerald SM, Prayther DC, Lee SA, Chi DS, Krishnaswamy G. Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein. Respir Res 2005;6:105.